Labiana Health, S.A. (BME:LAB)
3.440
0.00 (0.00%)
At close: May 23, 2025, 5:30 PM CET
Labiana Health Company Description
Labiana Health, S.A. develops, manufactures, sells, and markets animal and human health medicine products in Spain, rest of European Union, and internationally.
The company offers anesthetics-sedative, anti-infective, anti-inflammatory, antiparasitic, hormonal, and nutritional products; metabolism regulators; and vitamin products.
It also provides sterile, lyophilized, and biological formats; and Fosfomycin trometamol under the Fosfomicina Labiana brand name.
In addition, the company offers contract developments and manufacturing services. Labiana Health S.A. was founded in 1958 and is based in Pozuelo de Alarcón, Spain.
Labiana Health, S.A.
Country | Spain |
Founded | 1958 |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
Employees | 433 |
CEO | Manuel Ortega |
Contact Details
Address: Avenida de Europa Pozuelo de Alarcón, 28023 Spain | |
Phone | 34 919 91 26 28 |
Website | labiana.com |
Stock Details
Ticker Symbol | LAB |
Exchange | Madrid Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | EUR |
ISIN Number | ES0105638003 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Manuel Ramos Ortega | President, Chief Executive Officer and Director |
Ignacio Yanez Minondo | Executive Director |
Sandra Villagrasa Clemente | Executive Director |